TxAgent is a web-based AI-driven platform designed to accelerate translational research and clinical decision support by analyzing multi-omics and clinical datasets. Users upload patient gene expression or mutation profiles, configure disease context and drug libraries, and run an automated pipeline that integrates network biology, machine learning models, and drug-target interaction databases. The agent returns ranked lists of single and combination therapies, toxicity-adjusted scores, pathway enrichment analyses, and interactive network visualizations to guide experimental design and therapeutic hypotheses.

AI-Twin is a cutting-edge technology that fuses engineered 3D multi-tissue constructs, derived from patient biopsies, with digital twins. These computational models simulate biological behavior, providing an advanced platform for personalized medicine, biomedical research, and clinical applications. AI-Twin stands at the forefront of healthcare innovation, accelerating the pathophysiological understanding and the development of individualized treatments.

The Primary Care Giver is an advanced AI health assistant. It aims to streamline healthcare management by offering personalized advice, reminders for medication, updates on health status, and other health-related information tailored to individual needs. This tool helps bridge the gap between users and healthcare services, ensuring that critical health management tasks are never overlooked.

先見基因科技 specializes in genetic testing that empowers individuals with detailed insights into their health risks and genetic predispositions. By leveraging state-of-the-art technology and a highly qualified research team, the company provides actionable health information, enabling personalized medical strategies. Their focus on high-throughput sequencing technology aids in delivering precise risk assessments for various diseases, ensuring that individuals can make informed health-related choices.